Summary

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.


Strengths

● The company is in a robust financial situation considering its net cash and margin position.

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.57 for the 2021 fiscal year.

● The company's share price in relation to its net book value makes it look relatively cheap.

● The company has a low valuation given the cash flows generated by its activity.

● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's earnings growth outlook lacks momentum and is a weakness.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● Over the past twelve months, analysts' opinions have been revised negatively.